NIH Ends Funding for Research Using Human Fetal Tissue

On January 22, 2026, the National Institutes of Health (NIH) announced a significant policy change, ending all funding for research involving human fetal tissue obtained from elective abortions. This decision reinstates a ban originally implemented during President Donald Trump's first term, which had been reversed by President Joe Biden in 2021. The NIH stated that it will no longer support grants, cooperative agreements, or contracts that involve human fetal tissue, marking a decisive shift in federal research funding priorities.

Trump administration ends federally funded research with fetal tissue from elective abortionsNIH imposes full ban of aborted fetal tissue in researchNIH ends funding of research that uses human fetal tissue from abortionsNIH Ends Funding for Research Using Human Fetal TissueNIH Announces Major Policy Shift to End Use of Human Fetal Tissue in NIH-Supported ResearchTrump administration halts use of human fetal tissue in NIH-funded researchTrump Team Slaps New Ban on Fetal Tissue Research at NIH LabsNIH ends fetal tissue researchNIH Announces Shift Away from Human Fetal Tissue Research to Accelerate Biomedical Innovation

The use of human fetal tissue in biomedical research has been a contentious issue, with advocates arguing for its necessity in studying diseases and developing treatments, while opponents cite ethical concerns. Historically, fetal tissue has been crucial in research related to various diseases, including cancer, HIV, and neurological disorders. The NIH reported a decline in funding for such research, with only 77 projects supported in fiscal year 2024, down from $115 million allocated in 2018.

NIH imposes full ban of aborted fetal tissue in researchNIH Ends Funding for Research Using Human Fetal TissueNIH ends fetal tissue researchNIH ends funding of research that uses human fetal tissue from abortionsTrump Administration Cuts Off Funding for Fetal Tissue Research. Again.NIH Announces Shift Away from Human Fetal Tissue Research to Accelerate Biomedical InnovationNIH Announces Major Policy Shift to End Use of Human Fetal Tissue in NIH-Supported ResearchTrump administration halts use of human fetal tissue in NIH-funded researchTrump Team Slaps New Ban on Fetal Tissue Research at NIH Labs

NIH Director Dr. Jay Bhattacharya emphasized that the decision aims to modernize biomedical science by investing in alternative research technologies, such as organoids and computational models. He stated, “NIH is pushing American biomedical science into the 21st century,” indicating a focus on advancing scientific methods that align with contemporary ethical standards.

NIH Announces Major Policy Shift to End Use of Human Fetal Tissue in NIH-Supported Research

The policy has faced substantial criticism from the scientific community. Experts argue that fetal tissue remains irreplaceable for certain types of research, particularly in understanding human development and disease. Tyler Lamb, director of policy for the International Society for Stem Cell Research, remarked, “Human fetal tissue research has been indispensable to biomedical progress and remains the gold standard for revealing how human cells and organs form.” Critics assert that the ban is politically motivated rather than based on scientific merit.

NIH Ends Funding for Research Using Human Fetal Tissue

While the NIH's decision reflects a broader trend of declining funding for fetal tissue research, some scientists contend that alternatives cannot fully replicate the unique biological insights provided by fetal tissue. Jerome Zack, a professor at UCLA, noted, “There are no good alternatives,” highlighting the potential setbacks in research that the ban may cause.

NIH Ends Funding for Research Using Human Fetal Tissue

In light of the new policy, researchers are now faced with the challenge of adapting their projects. The NIH has indicated that existing grants can be rebudgeted to redirect funds away from fetal tissue research. Additionally, the agency plans to seek public comment on emerging biotechnologies that could further reduce reliance on human embryonic stem cells.

Trump administration halts use of human fetal tissue in NIH-funded research

The NIH's decision to end funding for research using human fetal tissue from elective abortions marks a pivotal moment in U.S. biomedical research policy. As the agency shifts its focus toward alternative research methodologies, the implications for ongoing and future studies remain to be fully understood, with many in the scientific community expressing concern over the potential impact on medical advancements.

NIH ends funding of research that uses human fetal tissue from abortions